Aug 11, 2020
List Labs Fields Upgraded Management Team
Jun 22, 2020
FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX® (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity
May 12, 2020
Galderma Announces Top-Line Results of Clinical Study Showing Patients Treated with Dysport® (abobotulinumtoxinA) Achieved High Levels of Satisfaction and Natural-Looking Results with Two Treatments Per Year
Jan 07, 2020
More Millennials are Turning to Cosmetic Procedures than Ever Before, says Beverly Hills Physicians
Dec 16, 2019
BOTOX® (onabotulinumtoxinA) Celebrates 30 Years of Endless Innovation
Dec 10, 2019
Cutting-Edge Cosmetics Injectables Center Set to Beautify the Valley
Nov 07, 2019
Xeomin Cosmetic® Licensed for Additional Indications In Canada
Oct 22, 2019
Revelations from Royal Sarah Ferguson Reveal Growing Use of a Range of Cosmetic Procedures for All Kinds of People, says Beverly Hills Physicians
Oct 09, 2019
Galderma Announces Positive Phase 2 Results for its Proprietary Liquid Formulation of an Investigational Botulinum Toxin and Approval of New State-of-the-Art Manufacturing Facility
Aug 26, 2019
FDA Approves US WorldMeds' MYOBLOC® (rimabotulinumtoxinB) Injection for Chronic Sialorrhea
Jul 09, 2019
Dermata Therapeutics Announces Positive Results from a Phase 1 Clinical Trial of DMT410, A New Topical Delivery Mechanism for Botulinum Toxin
Jun 21, 2019
FDA Approves BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
Jun 05, 2019
Ipsen's Dysport® (Clostridium Botulinum Type a Toxin-haemagglutinin Complex) Becomes First and Only Botulinum Toxin Type A to be Granted a Licence Update for Administration by Healthcare Professionals, Such as Physiotherapists, in the UK
May 30, 2019
Object Pharma Announces Strategic Acquisition of Metabiologics
May 29, 2019
DelNova Selected to Present at the 2019 Start-Up Stadium during BIO 2019
May 13, 2019
AEON Biopharma Appoints BOTOX® Therapeutic Head as President and Chief Executive Officer
Mar 14, 2019
L. Andrew Koman, MD, recognized by AAOS for 30 years of botulinum toxin and cerebral palsy research
Mar 07, 2019
FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
Jan 28, 2019
New BOTOX® Cosmetic (onabotulinumtoxinA) "Own Your Look" Campaign Brings Fresh Face To Trusted Brand
Jan 28, 2019
Global Botulinum Toxin Industry